Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis

The American Review of Respiratory Disease
E P TrulockR Genton

Abstract

A heart-lung transplant recipient with pulmonary disease caused by the rapidly growing nontuberculous Mycobacterium chelonae and obliterative bronchiolitis is presented. The clinical features, course, and management of the mycobacterial disease and the obliterative bronchiolitis are discussed. The role of transbronchial lung biopsy in determining the significance of rapidly growing mycobacteria in pulmonary specimens and in diagnosing infection and rejection is emphasized.

Citations

Jan 10, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C BlauwendraatK A Harris
Mar 19, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Rick M FairhurstAbbas Ardehali
Feb 15, 2002·Transplant Infectious Disease : an Official Journal of the Transplantation Society·G S Nagy, R H Rubin
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R Speich, W van der Bij
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Karen Doucette, Jay A Fishman
May 1, 1996·The Pediatric Infectious Disease Journal·M J ChusidK S Kehl
Oct 1, 1991·Journal of Clinical Pathology·S Stewart, N Cary
Jun 1, 1992·Journal of Clinical Pathology·J PaulD V Parums
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Apr 13, 2011·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Hsuanwen C HuangJohn A Belperio
Nov 28, 2012·Transplant Infectious Disease : an Official Journal of the Transplantation Society·L E RicheyD Mushatt
Mar 31, 2004·La Revue de médecine interne·M FournierO Groussard
Aug 8, 2006·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jennifer L Taylor, Scott M Palmer
Apr 17, 1999·Clinics in Chest Medicine·E P Trulock
Mar 29, 2002·Infectious Disease Clinics of North America·Deborah L Ebert, Kenneth N Olivier
Oct 10, 2002·Clinics in Chest Medicine·Charles L Daley, David E Griffith
Apr 20, 2010·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Marita GilljamAnnika Ericsson Hollsing
Jul 3, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·S K ShahV G Valentine
Oct 10, 2002·Clinics in Chest Medicine·Deborah L Ebert, Kenneth N Olivier
Nov 11, 2006·Journal of Intensive Care Medicine·Jennifer L Taylor, Scott M Palmer
Dec 9, 2008·Current Opinion in Organ Transplantation·Paul A Corris
May 1, 1993·The American Review of Respiratory Disease·D E GriffithR J Wallace
May 25, 2021·Seminars in Respiratory and Critical Care Medicine·Daniel Z P Friedman, Karen Doucette
Jan 1, 1997·Clinical Microbiology Reviews·R Patel, C V Paya
Oct 12, 2021·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Razelle GrimesKellie J Goodlet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.